Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair

NCT05053334 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Omalizumab Prefilled Syringe

Sponsor

Syneos Health

Collaborators

[object Object]